S&P 500   5,056.99 (-0.10%)
DOW   37,875.65 (+0.37%)
QQQ   431.32 (+0.06%)
AAPL   172.51 (-0.10%)
MSFT   414.91 (+0.31%)
META   499.47 (-0.15%)
GOOGL   154.56 (-0.19%)
AMZN   183.75 (+0.07%)
TSLA   157.62 (-2.39%)
NVDA   866.00 (+0.70%)
AMD   162.38 (+1.28%)
NIO   3.75 (-3.60%)
BABA   70.16 (-0.65%)
T   16.27 (+0.18%)
F   12.19 (-0.33%)
MU   120.00 (-1.13%)
GE   153.75 (+0.03%)
CGC   6.71 (-3.87%)
DIS   112.73 (-0.19%)
AMC   2.45 (-0.81%)
PFE   25.88 (-0.12%)
PYPL   62.86 (-1.02%)
XOM   118.90 (-0.65%)
S&P 500   5,056.99 (-0.10%)
DOW   37,875.65 (+0.37%)
QQQ   431.32 (+0.06%)
AAPL   172.51 (-0.10%)
MSFT   414.91 (+0.31%)
META   499.47 (-0.15%)
GOOGL   154.56 (-0.19%)
AMZN   183.75 (+0.07%)
TSLA   157.62 (-2.39%)
NVDA   866.00 (+0.70%)
AMD   162.38 (+1.28%)
NIO   3.75 (-3.60%)
BABA   70.16 (-0.65%)
T   16.27 (+0.18%)
F   12.19 (-0.33%)
MU   120.00 (-1.13%)
GE   153.75 (+0.03%)
CGC   6.71 (-3.87%)
DIS   112.73 (-0.19%)
AMC   2.45 (-0.81%)
PFE   25.88 (-0.12%)
PYPL   62.86 (-1.02%)
XOM   118.90 (-0.65%)
S&P 500   5,056.99 (-0.10%)
DOW   37,875.65 (+0.37%)
QQQ   431.32 (+0.06%)
AAPL   172.51 (-0.10%)
MSFT   414.91 (+0.31%)
META   499.47 (-0.15%)
GOOGL   154.56 (-0.19%)
AMZN   183.75 (+0.07%)
TSLA   157.62 (-2.39%)
NVDA   866.00 (+0.70%)
AMD   162.38 (+1.28%)
NIO   3.75 (-3.60%)
BABA   70.16 (-0.65%)
T   16.27 (+0.18%)
F   12.19 (-0.33%)
MU   120.00 (-1.13%)
GE   153.75 (+0.03%)
CGC   6.71 (-3.87%)
DIS   112.73 (-0.19%)
AMC   2.45 (-0.81%)
PFE   25.88 (-0.12%)
PYPL   62.86 (-1.02%)
XOM   118.90 (-0.65%)
S&P 500   5,056.99 (-0.10%)
DOW   37,875.65 (+0.37%)
QQQ   431.32 (+0.06%)
AAPL   172.51 (-0.10%)
MSFT   414.91 (+0.31%)
META   499.47 (-0.15%)
GOOGL   154.56 (-0.19%)
AMZN   183.75 (+0.07%)
TSLA   157.62 (-2.39%)
NVDA   866.00 (+0.70%)
AMD   162.38 (+1.28%)
NIO   3.75 (-3.60%)
BABA   70.16 (-0.65%)
T   16.27 (+0.18%)
F   12.19 (-0.33%)
MU   120.00 (-1.13%)
GE   153.75 (+0.03%)
CGC   6.71 (-3.87%)
DIS   112.73 (-0.19%)
AMC   2.45 (-0.81%)
PFE   25.88 (-0.12%)
PYPL   62.86 (-1.02%)
XOM   118.90 (-0.65%)
LON:SCLP

Scancell (SCLP) Share Price, News & Analysis

GBX 9.74
-0.11 (-1.12%)
(As of 01:39 PM ET)
Today's Range
9.50
9.88
50-Day Range
9.70
12
52-Week Range
7.59
21
Volume
299,307 shs
Average Volume
433,417 shs
Market Capitalization
£90.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SCLP stock logo

About Scancell Stock (LON:SCLP)

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer. It also develops Modi-1, a citrullinated peptides vaccine that is in phase I/II clinical trials for the treatment of solid tumors including triple negative breast, ovarian, renal, and head and neck cancers; and Modi-2, which targets homocitrullinated cancer antigens. In addition, the company focuses to develop SCOV1 and SCOV2 COVIDITY, a DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.

SCLP Stock Price History

SCLP Stock News Headlines

Elon Musk’s ChatGPT Could Soon Mint New Millionaires
Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.
Scancell Holdings Share Chat
Scancell Holdings plc (SCP.F)
Elon Musk’s ChatGPT Could Soon Mint New Millionaires
Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.
Scancell fundraiser brings in £10.7m after it is 'upsized'
Scancell shares are on fire! Should I buy?
Scancell jumps 23% after trial data; analysts hail results
Scancell jump 23% after trial data; analysts hail results
Scancell appoints head of business development
Scancell Plc (LSE: SCLP)
See More Headlines
Receive SCLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scancell and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/31/2020
Today
4/16/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
51
Year Founded
N/A

Profitability

Net Income
£-9,530,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£5.27 million
Cash Flow
GBX 1.24 per share
Book Value
GBX (1) per share

Miscellaneous

Free Float
N/A
Market Cap
£90.37 million
Optionable
Not Optionable
Beta
0.34
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Prof. Lindy Gillian Durrant Ph.D. (Age 67)
    Founder, CEO, Chief Scientific Officer & Director
    Comp: $369.12k
  • Dr. Sally Elizabeth Adams (Age 63)
    Executive Officer
    Comp: $253.51k
  • Mr. Sathijeevan Nirmalananthan (Age 38)
    CFO & Director
  • Dr. Samantha Paston Ph.D.
    Head of Translational Research
  • Dr. Adrian Parry Ph.D.
    Head of Manufacturing
  • Dr. Mandeep Sehmi
    Head of Business Development
  • Dr. Callum Scotthasbeen
    Head of Development
  • Mr. Keith Charles Green
    Company Secretary

SCLP Stock Analysis - Frequently Asked Questions

How have SCLP shares performed in 2024?

Scancell's stock was trading at GBX 10.50 at the beginning of 2024. Since then, SCLP stock has decreased by 7.2% and is now trading at GBX 9.74.
View the best growth stocks for 2024 here
.

How were Scancell's earnings last quarter?

Scancell Holdings plc (LON:SCLP) posted its quarterly earnings data on Friday, January, 31st. The company reported ($0.56) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Scancell own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Scancell investors own include KAZ Minerals (KAZ), Standard Chartered (STAN), Petropavlovsk (POG), AorTech International (AOR), Ascential (ASCL), Advanced Oncotherapy (AVO), Empyrean Energy (EME), Lloyds Banking Group (LYG), Aminex (AEX) and Sound Energy (SOU).

How do I buy shares of Scancell?

Shares of SCLP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SCLP) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners